Arcturus Therapeutics Holdings Inc (ARCT) Stock Price, Quote, News & History

ARCTNASDAQ
$15.63
-0.19-1.2%
At close: Sep 8, 5:00 PM EST
$15.37
-0.26-1.66%
After Hours: 9:02 AM EST

Arcturus Therapeutics (ARCT) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-72.73M
Investing Cash Flow (TTM)
-41.00K
Financing Cash Flow (TTM)
12.93M
Free Cash Flow (TTM)
-72.82M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-59.84M

Analyst Trends and Forecast

1
Mar
1
Jul
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$281.10M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
23.69
PB Ratio (TTM)
2.62
Earnings Yield % (TTM)
-21.05%
Earnings Yield % (FWD)
-20.16%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$6.04

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
$0
LT Debt Repayment (TTM)
$0
Total Cash
$191.48M
Debt to Equity
0.13
Issuance of Debt (TTM)
$0
Repayment of Debt (TTM)
$0

Key Statistics

Open
$15.47
Close
$15.63
Volume / Avg.
641.20K / 818.23K
Day Range
$14.77 - $15.86
52 Wk Range
5.50 - 24.17
Market Cap
$436.86M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
71
Short Interest
28.56%
Days to Cover
9.86

About

Sector
Health Care
Industry
Biotechnology
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Arcturus Therapeutics (ARCT) stock?

A

You can purchase shares of Arcturus Therapeutics (NASDAQ:ARCT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Arcturus Therapeutics (ARCT) competitors?

Q

What is the forecast, or price target, for Arcturus Therapeutics (ARCT) stock?

A

Arcturus Therapeutics has a consensus price target of $33.08.

Q

What is the current price for Arcturus Therapeutics (ARCT)?

A

The stock price for Arcturus Therapeutics (NASDAQ: ARCT) is $15.37 last updated September 8, 2026 at 9:02 AM EDT.

Q

Does Arcturus Therapeutics (ARCT) pay a dividend?

A

There are no upcoming dividends for Arcturus Therapeutics.

Q

When is Arcturus Therapeutics (NASDAQ:ARCT) reporting earnings?

A

Arcturus Therapeutics does not have any upcoming earnings scheduled.

Q

Is Arcturus Therapeutics (ARCT) going to split?

A

There is no upcoming split for Arcturus Therapeutics.

Q

What sector and industry does Arcturus Therapeutics (ARCT) operate in?

A

Arcturus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.